Skip to main content
Erschienen in: European Journal of Plastic Surgery 2/2017

18.02.2017 | Review

Platelet biology and the rationale of PRP therapy in chronic wounds

verfasst von: Domantas Rainys, Gediminas Samulėnas, Mantas Kievišas, Eglė Samulėnienė, Loreta Pilipaitytė, Rytis Rimdeika

Erschienen in: European Journal of Plastic Surgery | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

For the past four decades, platelets have been thought to function only in hemostatic processes. With reference to recent research, today, it is known that platelets also play important roles in tissue regeneration and immunological processes. The keystone of the use of platelet-rich plasma (PRP) for the treatment of chronic wounds lays in the molecular composition of thrombocytes, which are rich in growth factors and other biologically active substances. PRP forms a matrix for cells and thus promotes wound healing processes. Harvesting PRP is relatively uncomplicated, minimally invasive, and potentially available for each patient. In this review, we provide an overview of the biology of the thrombocyte to better understand the effects of PRP. Additionally, we reviewed published studies, analyzing the effectiveness of PRP for the treatment of chronic wounds.
Level of evidence: Not ratable.
Literatur
1.
Zurück zum Zitat Atiyeh BS, Ioannovich J, Al-Amm CA, El-Musa KA (2002) Management of acute and chronic open wounds: the importance of moist environment in optimal wound healing. Curr Pharm Biotechnol 3:179–195CrossRefPubMed Atiyeh BS, Ioannovich J, Al-Amm CA, El-Musa KA (2002) Management of acute and chronic open wounds: the importance of moist environment in optimal wound healing. Curr Pharm Biotechnol 3:179–195CrossRefPubMed
2.
Zurück zum Zitat Mast BA (1992) The skin. In: Cohen IK, Diegelmann RF, Lindblad WJ (eds) Wound heal, Biochem. Clin. Asp. W.B. Saunders Company, Philadelphia, pp 344–355 Mast BA (1992) The skin. In: Cohen IK, Diegelmann RF, Lindblad WJ (eds) Wound heal, Biochem. Clin. Asp. W.B. Saunders Company, Philadelphia, pp 344–355
4.
Zurück zum Zitat Broughton G 2nd, Janis JE, Attinger CE (2006) The basic science of wound healing. Plast Reconstr Surg 117:12S–34SCrossRefPubMed Broughton G 2nd, Janis JE, Attinger CE (2006) The basic science of wound healing. Plast Reconstr Surg 117:12S–34SCrossRefPubMed
5.
Zurück zum Zitat Lazarus GS, Cooper DM, Knighton DR et al (1994) Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 130:489–493CrossRefPubMed Lazarus GS, Cooper DM, Knighton DR et al (1994) Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 130:489–493CrossRefPubMed
6.
Zurück zum Zitat Markova A, Mostow EN (2012) US skin disease assessment: ulcer and wound care. Dermatol Clin 30:107–111CrossRefPubMed Markova A, Mostow EN (2012) US skin disease assessment: ulcer and wound care. Dermatol Clin 30:107–111CrossRefPubMed
7.
Zurück zum Zitat Driver VR, Hanft J, Fylling CP et al (2006) A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manag 52:68–87 Driver VR, Hanft J, Fylling CP et al (2006) A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manag 52:68–87
8.
Zurück zum Zitat Anitua E, Aguirre JJ, Algorta J et al (2008) Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res-Part B Appl Biomater 84:415–421CrossRefPubMed Anitua E, Aguirre JJ, Algorta J et al (2008) Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res-Part B Appl Biomater 84:415–421CrossRefPubMed
9.
Zurück zum Zitat Lana JF, Weglein A, Vicente E et al (2013) Platelet rich plasma and its growth factors: the state of the art. In: Lana JFSD, Santana MHA, Belangero WD, Luzo ACM (eds) Platelet-rich plasma, Regen. Med. Sport. Med. Orthop. Recover. Musculoskelet. Inj. Springer Science & Business Media, Berlin Heidelberg, pp 1–59 Lana JF, Weglein A, Vicente E et al (2013) Platelet rich plasma and its growth factors: the state of the art. In: Lana JFSD, Santana MHA, Belangero WD, Luzo ACM (eds) Platelet-rich plasma, Regen. Med. Sport. Med. Orthop. Recover. Musculoskelet. Inj. Springer Science & Business Media, Berlin Heidelberg, pp 1–59
10.
Zurück zum Zitat (2001) Pressure ulcers in America: prevalence, incidence, and implications for the future. An executive summary of the National Pressure Ulcer Advisory Panel monograph. Adv Skin Wound Care 14:208–215 (2001) Pressure ulcers in America: prevalence, incidence, and implications for the future. An executive summary of the National Pressure Ulcer Advisory Panel monograph. Adv Skin Wound Care 14:208–215
11.
Zurück zum Zitat Gottrup F (2004) A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg. doi:10.1016/S0002-9610(03)00303-9 Gottrup F (2004) A specialized wound-healing center concept: importance of a multidisciplinary department structure and surgical treatment facilities in the treatment of chronic wounds. Am J Surg. doi:10.​1016/​S0002-9610(03)00303-9
12.
Zurück zum Zitat Gottrup F, Holstein P, Jorgensen B et al (2001) A new concept of a multidisciplinary wound healing center and a national expert function of wound healing. Arch Surg 136:765–772CrossRefPubMed Gottrup F, Holstein P, Jorgensen B et al (2001) A new concept of a multidisciplinary wound healing center and a national expert function of wound healing. Arch Surg 136:765–772CrossRefPubMed
13.
Zurück zum Zitat Golinko MS, Clark S, Rennert R et al (2009) Wound emergencies: the importance of assessment, documentation, and early treatment using a wound electronic medical record. Ostomy Wound Manage 55:54–61PubMed Golinko MS, Clark S, Rennert R et al (2009) Wound emergencies: the importance of assessment, documentation, and early treatment using a wound electronic medical record. Ostomy Wound Manage 55:54–61PubMed
14.
Zurück zum Zitat Cancela AM, Lana JF, Annichino-Bizzachi JM et al (2013) Use of platelet-rich plasma (PRP) in treating chronic wounds. In: Lana JFSD, Santana MHA, Belangero WD, Luzo ACM (eds) Platelet-rich plasma—Regen, Med. Sport. Med. Orthop. Recover. Musculoskelet. Inj. Springer Science & Business Media, Berlin Heidelberg, pp 281–288 Cancela AM, Lana JF, Annichino-Bizzachi JM et al (2013) Use of platelet-rich plasma (PRP) in treating chronic wounds. In: Lana JFSD, Santana MHA, Belangero WD, Luzo ACM (eds) Platelet-rich plasma—Regen, Med. Sport. Med. Orthop. Recover. Musculoskelet. Inj. Springer Science & Business Media, Berlin Heidelberg, pp 281–288
15.
Zurück zum Zitat Yuan T, Zhang C, Tang M et al (2009) Autologous platelet-rich plasma enhances healing of chronic wounds. Wounds A Compend Clin Res {&} Pract 21:280–286 Yuan T, Zhang C, Tang M et al (2009) Autologous platelet-rich plasma enhances healing of chronic wounds. Wounds A Compend Clin Res {&} Pract 21:280–286
16.
Zurück zum Zitat White JG (2013) Platelet structure. In: Michelson AD (ed) Platelets, 3rd edn. Academic Press, Oxford, pp 117–144CrossRef White JG (2013) Platelet structure. In: Michelson AD (ed) Platelets, 3rd edn. Academic Press, Oxford, pp 117–144CrossRef
17.
Zurück zum Zitat Flaumenhaft R (2013) Platelet secretion. In: Michelson AD (ed) Platelets, 3rd edn. Academic Press, Oxford, pp 343–366CrossRef Flaumenhaft R (2013) Platelet secretion. In: Michelson AD (ed) Platelets, 3rd edn. Academic Press, Oxford, pp 343–366CrossRef
18.
Zurück zum Zitat Gerrard JM, Rao GH, White JG (1977) The influence of reserpine and ethylenediaminetetraacetic acid (EDTA) on serotonin storage organelles of blood platelets. Am J Pathol 87:633–646PubMedPubMedCentral Gerrard JM, Rao GH, White JG (1977) The influence of reserpine and ethylenediaminetetraacetic acid (EDTA) on serotonin storage organelles of blood platelets. Am J Pathol 87:633–646PubMedPubMedCentral
19.
Zurück zum Zitat Rendu F, Brohard-Bohn B (2001) The platelet release reaction: granules’ constituents, secretion and functions. Platelets 12:261–273CrossRefPubMed Rendu F, Brohard-Bohn B (2001) The platelet release reaction: granules’ constituents, secretion and functions. Platelets 12:261–273CrossRefPubMed
20.
Zurück zum Zitat Burnstock G (2002) Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22:364–373CrossRefPubMed Burnstock G (2002) Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22:364–373CrossRefPubMed
21.
Zurück zum Zitat Lansdown ABG (2002) Calcium: a potential central regulator in wound healing in the skin. Wound Repair Regen 10:271–285CrossRefPubMed Lansdown ABG (2002) Calcium: a potential central regulator in wound healing in the skin. Wound Repair Regen 10:271–285CrossRefPubMed
22.
Zurück zum Zitat Rozman P, Semenic D, Smrke DM (2011) The role of platelet gel in regenerative medicine. In: Wislet-Gendebien S (ed) Adv. Regen. Med. InTech, pp 319–348 Rozman P, Semenic D, Smrke DM (2011) The role of platelet gel in regenerative medicine. In: Wislet-Gendebien S (ed) Adv. Regen. Med. InTech, pp 319–348
23.
Zurück zum Zitat Anitua E, Andia I, Ardanza B et al (2004) Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91:4–15PubMed Anitua E, Andia I, Ardanza B et al (2004) Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91:4–15PubMed
24.
Zurück zum Zitat von Hundelshausen P, Petersen F, Brandt E (2007) Platelet-derived chemokines in vascular biology. Thromb Haemost 97:704–713 von Hundelshausen P, Petersen F, Brandt E (2007) Platelet-derived chemokines in vascular biology. Thromb Haemost 97:704–713
25.
26.
Zurück zum Zitat Zhou YQ, Levesque JP, Hatzfeld A et al (1993) Fibrinogen potentiates the effect of interleukin-3 on early human hematopoietic progenitors. Blood 82:800–806PubMed Zhou YQ, Levesque JP, Hatzfeld A et al (1993) Fibrinogen potentiates the effect of interleukin-3 on early human hematopoietic progenitors. Blood 82:800–806PubMed
27.
Zurück zum Zitat Larivière B, Rouleau M, Picard S, Beaulieu AD (2003) Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects. Wound Repair Regen 11:79–89CrossRefPubMed Larivière B, Rouleau M, Picard S, Beaulieu AD (2003) Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects. Wound Repair Regen 11:79–89CrossRefPubMed
28.
Zurück zum Zitat Minor KH, Peterson CB (2002) Plasminogen activator inhibitor type 1 promotes the self-association of vitronectin into complexes exhibiting altered incorporation into the extracellular matrix. J Biol Chem 277:10337–10345CrossRefPubMed Minor KH, Peterson CB (2002) Plasminogen activator inhibitor type 1 promotes the self-association of vitronectin into complexes exhibiting altered incorporation into the extracellular matrix. J Biol Chem 277:10337–10345CrossRefPubMed
29.
Zurück zum Zitat Mosnier LO, Buijtenhuijs P, Marx PF et al (2003) Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets. Blood 101:4844–4846CrossRefPubMed Mosnier LO, Buijtenhuijs P, Marx PF et al (2003) Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets. Blood 101:4844–4846CrossRefPubMed
30.
Zurück zum Zitat Carmeliet P, Mackman N, Moons L et al (1996) Role of tissue factor in embryonic blood vessel development. Nature 383:73–75CrossRefPubMed Carmeliet P, Mackman N, Moons L et al (1996) Role of tissue factor in embryonic blood vessel development. Nature 383:73–75CrossRefPubMed
31.
Zurück zum Zitat Fan Z, Larson PJ, Bognacki J et al (1998) Tissue factor regulates plasminogen binding and activation. Blood 91:1987–1998PubMed Fan Z, Larson PJ, Bognacki J et al (1998) Tissue factor regulates plasminogen binding and activation. Blood 91:1987–1998PubMed
32.
Zurück zum Zitat Sato Y, Asada Y, Marutsuka K et al (1996) Tissue factor induces migration of cultured aortic smooth muscle cells. Thromb Haemost 75:389–392PubMed Sato Y, Asada Y, Marutsuka K et al (1996) Tissue factor induces migration of cultured aortic smooth muscle cells. Thromb Haemost 75:389–392PubMed
33.
Zurück zum Zitat Zarbock A, Singbartl K, Ley K (2006) Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 116:3211–3219CrossRefPubMedPubMedCentral Zarbock A, Singbartl K, Ley K (2006) Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest 116:3211–3219CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Gear ARL, Camerini D (2003) Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 10:335–350CrossRefPubMed Gear ARL, Camerini D (2003) Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 10:335–350CrossRefPubMed
35.
Zurück zum Zitat Kasper B, Brandt E, Bulfone-Paus S, Petersen F (2004) Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase. Blood 103:1602–1610CrossRefPubMed Kasper B, Brandt E, Bulfone-Paus S, Petersen F (2004) Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase. Blood 103:1602–1610CrossRefPubMed
36.
Zurück zum Zitat Brandt E, Petersen F, Ludwig A et al (2000) The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J Leukoc Biol 67:471–478PubMed Brandt E, Petersen F, Ludwig A et al (2000) The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J Leukoc Biol 67:471–478PubMed
37.
Zurück zum Zitat Scheld WM, Valone JA, Sande MA (1978) Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest 61:1394–1404CrossRefPubMedPubMedCentral Scheld WM, Valone JA, Sande MA (1978) Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J Clin Invest 61:1394–1404CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Klinger MHF, Jelkmann W (2002) Role of blood platelets in infection and inflammation. J Interf Cytokine Res 22:913–922CrossRef Klinger MHF, Jelkmann W (2002) Role of blood platelets in infection and inflammation. J Interf Cytokine Res 22:913–922CrossRef
39.
Zurück zum Zitat Krijgsveld J, Zaat SA, Meeldijk J et al (2000) Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 275:20374–20381CrossRefPubMed Krijgsveld J, Zaat SA, Meeldijk J et al (2000) Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem 275:20374–20381CrossRefPubMed
41.
Zurück zum Zitat Maynard DM, Heijnen HFG, Horne MK et al (2007) Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 5:1945–1955CrossRefPubMed Maynard DM, Heijnen HFG, Horne MK et al (2007) Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 5:1945–1955CrossRefPubMed
42.
Zurück zum Zitat Del Conde I, Crúz MA, Zhang H et al (2005) Platelet activation leads to activation and propagation of the complement system. J Exp Med 201:871–879CrossRefPubMedPubMedCentral Del Conde I, Crúz MA, Zhang H et al (2005) Platelet activation leads to activation and propagation of the complement system. J Exp Med 201:871–879CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Devine DV, Rosse WF (1987) Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H. Proc Natl Acad Sci U S A 84:5873–5877CrossRefPubMedPubMedCentral Devine DV, Rosse WF (1987) Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H. Proc Natl Acad Sci U S A 84:5873–5877CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Anitua E, Andía I, Sanchez M et al (2005) Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 23:281–286CrossRefPubMed Anitua E, Andía I, Sanchez M et al (2005) Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 23:281–286CrossRefPubMed
45.
Zurück zum Zitat Molloy T, Wang Y, Murrell GAC (2003) The roles of growth factors in tendon and ligament healing. Sport Med 33:381–394CrossRef Molloy T, Wang Y, Murrell GAC (2003) The roles of growth factors in tendon and ligament healing. Sport Med 33:381–394CrossRef
46.
Zurück zum Zitat Bennett SP, Griffiths GD, Schor AM et al (2003) Growth factors in the treatment of diabetic foot ulcers. Br J Surg 90:133–146CrossRefPubMed Bennett SP, Griffiths GD, Schor AM et al (2003) Growth factors in the treatment of diabetic foot ulcers. Br J Surg 90:133–146CrossRefPubMed
47.
Zurück zum Zitat Jiménez B, Volpert OV, Crawford SE et al (2000) Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6:41–48CrossRefPubMed Jiménez B, Volpert OV, Crawford SE et al (2000) Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 6:41–48CrossRefPubMed
48.
Zurück zum Zitat Sulpice E, Bryckaert M, Lacour J et al (2002) Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway. Blood 100:3087–3094CrossRefPubMed Sulpice E, Bryckaert M, Lacour J et al (2002) Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway. Blood 100:3087–3094CrossRefPubMed
49.
Zurück zum Zitat Cheng Y, Austin SC, Rocca B et al (2002) Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296:539–541CrossRefPubMed Cheng Y, Austin SC, Rocca B et al (2002) Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296:539–541CrossRefPubMed
50.
Zurück zum Zitat Zhang Q, Peyruchaud O, French KJ et al (1999) Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a rho-dependent signal pathway. Blood 93:2984–2990PubMed Zhang Q, Peyruchaud O, French KJ et al (1999) Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a rho-dependent signal pathway. Blood 93:2984–2990PubMed
51.
Zurück zum Zitat Weyrich AS, Prescott SM, Zimmerman GA (2002) Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. Circulation 106:1433–1435CrossRefPubMed Weyrich AS, Prescott SM, Zimmerman GA (2002) Platelets, endothelial cells, inflammatory chemokines, and restenosis: complex signaling in the vascular play book. Circulation 106:1433–1435CrossRefPubMed
52.
Zurück zum Zitat Ross R, Glomset J, Kariya B, Harker L (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 71:1207–1210CrossRefPubMedPubMedCentral Ross R, Glomset J, Kariya B, Harker L (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A 71:1207–1210CrossRefPubMedPubMedCentral
53.
Zurück zum Zitat Witte LD, Kaplan KL, Nossel HL et al (1978) Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res 42:402–409CrossRefPubMed Witte LD, Kaplan KL, Nossel HL et al (1978) Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circ Res 42:402–409CrossRefPubMed
54.
Zurück zum Zitat Kaplan DR, Chao FC, Stiles CD et al (1979) Platelet alpha granules contain a growth factor for fibroblasts. Blood 53:1043–1052PubMed Kaplan DR, Chao FC, Stiles CD et al (1979) Platelet alpha granules contain a growth factor for fibroblasts. Blood 53:1043–1052PubMed
55.
Zurück zum Zitat Textor J (2013) Platelet-rich plasma (PRP) as a therapeutic agent: platelet biology, growth factors and a review of the literature. In: Lana JFSD, Santana MHA, Belangero WD, Luzo ACM (eds) Platelet-rich plasma, Regen. Med. Sport. Med. Orthop. Recover. Musculoskelet. Inj. Springer Science & Business Media, Berlin Heidelberg, pp 61–94 Textor J (2013) Platelet-rich plasma (PRP) as a therapeutic agent: platelet biology, growth factors and a review of the literature. In: Lana JFSD, Santana MHA, Belangero WD, Luzo ACM (eds) Platelet-rich plasma, Regen. Med. Sport. Med. Orthop. Recover. Musculoskelet. Inj. Springer Science & Business Media, Berlin Heidelberg, pp 61–94
56.
Zurück zum Zitat Dohan Ehrenfest DM, Rasmusson L, Albrektsson T (2009) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27:158–167CrossRefPubMed Dohan Ehrenfest DM, Rasmusson L, Albrektsson T (2009) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27:158–167CrossRefPubMed
57.
Zurück zum Zitat Everts PAM, Knape JTA, Weibrich G et al (2006) Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol 38:174–187PubMedPubMedCentral Everts PAM, Knape JTA, Weibrich G et al (2006) Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol 38:174–187PubMedPubMedCentral
58.
Zurück zum Zitat Moghazy AM, Ellabban MA, Adly OA, Ahmed FY (2015) Evaluation of the use of vacuum-assisted closure (VAC) and platelet-rich plasma gel (PRP) in management of complex wounds. Eur J Plast Surg 38:463–470CrossRef Moghazy AM, Ellabban MA, Adly OA, Ahmed FY (2015) Evaluation of the use of vacuum-assisted closure (VAC) and platelet-rich plasma gel (PRP) in management of complex wounds. Eur J Plast Surg 38:463–470CrossRef
59.
Zurück zum Zitat de Leon JM, Driver VR, Fylling CP et al (2011) The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. Adv Skin Wound Care 24:357–368CrossRefPubMed de Leon JM, Driver VR, Fylling CP et al (2011) The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. Adv Skin Wound Care 24:357–368CrossRefPubMed
60.
Zurück zum Zitat Dhurat R, Sukesh M (2014) Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg 7:189–197CrossRefPubMedPubMedCentral Dhurat R, Sukesh M (2014) Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg 7:189–197CrossRefPubMedPubMedCentral
61.
Zurück zum Zitat Everts PAM, Hoffmann J, Weibrich G et al (2006) Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus Med 16:363–368CrossRefPubMed Everts PAM, Hoffmann J, Weibrich G et al (2006) Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus Med 16:363–368CrossRefPubMed
62.
Zurück zum Zitat Dankert J, Krijgsveld J, van Der Werff J et al (2001) Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. J Infect Dis 184:597–605CrossRefPubMed Dankert J, Krijgsveld J, van Der Werff J et al (2001) Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. J Infect Dis 184:597–605CrossRefPubMed
63.
Zurück zum Zitat Tonnesen MG, Feng X, Clark RAF (2000) Angiogenesis in wound healing. In: J. Investig. Dermatology Symp. Proc, pp. 40–46 Tonnesen MG, Feng X, Clark RAF (2000) Angiogenesis in wound healing. In: J. Investig. Dermatology Symp. Proc, pp. 40–46
64.
Zurück zum Zitat Baum CL, Arpey CJ (2005) Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 31:674–686CrossRefPubMed Baum CL, Arpey CJ (2005) Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 31:674–686CrossRefPubMed
66.
Zurück zum Zitat Minami T, Horiuchi K, Miura M et al (2004) Vascular endothelial growth factor- and thrombin-induced termination factor, down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279:50537–50554CrossRefPubMed Minami T, Horiuchi K, Miura M et al (2004) Vascular endothelial growth factor- and thrombin-induced termination factor, down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279:50537–50554CrossRefPubMed
67.
Zurück zum Zitat Raza SL, Cornelius LA (2000) Matrix metalloproteinases: pro- and anti-angiogenic activities. In: J. Investig. Dermatology Symp. Proc, pp. 47–54 Raza SL, Cornelius LA (2000) Matrix metalloproteinases: pro- and anti-angiogenic activities. In: J. Investig. Dermatology Symp. Proc, pp. 47–54
68.
Zurück zum Zitat Lorenz HP, Longaker MT (2006) Wounds: biology, pathology, and management. In: Norton J, Bollinger RR, Chang AE et al (eds) Essent. Pract. Surgery, Basic Sci. Clin. Evid. Springer Science & Business Media, New York, pp 77–88 Lorenz HP, Longaker MT (2006) Wounds: biology, pathology, and management. In: Norton J, Bollinger RR, Chang AE et al (eds) Essent. Pract. Surgery, Basic Sci. Clin. Evid. Springer Science & Business Media, New York, pp 77–88
69.
Zurück zum Zitat Tharakan S, Pontiggia L, Biedermann T et al (2010) Transglutaminases, involucrin, and loricrin as markers of epidermal differentiation in skin substitutes derived from human sweat gland cells. Pediatr Surg Int 26:71–77CrossRefPubMed Tharakan S, Pontiggia L, Biedermann T et al (2010) Transglutaminases, involucrin, and loricrin as markers of epidermal differentiation in skin substitutes derived from human sweat gland cells. Pediatr Surg Int 26:71–77CrossRefPubMed
70.
Zurück zum Zitat Yang HS, Shin J, Bhang SH et al (2011) Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma. Exp Mol Med 43:622–629CrossRefPubMedPubMedCentral Yang HS, Shin J, Bhang SH et al (2011) Enhanced skin wound healing by a sustained release of growth factors contained in platelet-rich plasma. Exp Mol Med 43:622–629CrossRefPubMedPubMedCentral
71.
Zurück zum Zitat Carter MJ, Fylling CP, Parnell LKS (2011) Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty 11:382–410 Carter MJ, Fylling CP, Parnell LKS (2011) Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty 11:382–410
72.
Zurück zum Zitat Villela DL, Santos VLCG (2010) Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review. Growth Factors 28:111–116CrossRefPubMed Villela DL, Santos VLCG (2010) Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review. Growth Factors 28:111–116CrossRefPubMed
73.
Zurück zum Zitat Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I et al (2016) Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev 5:CD006899 Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I et al (2016) Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev 5:CD006899
74.
Zurück zum Zitat Friese G, Herten M, Scherbaum WA (2007) The use of autologous platelet concentrate activated by autologous thrombin (APC+) is effective and safe in the treatment of chronic diabetic foot ulcers: a randomized controlled trial. Fifth Int. Symp. Diabet. Foot Friese G, Herten M, Scherbaum WA (2007) The use of autologous platelet concentrate activated by autologous thrombin (APC+) is effective and safe in the treatment of chronic diabetic foot ulcers: a randomized controlled trial. Fifth Int. Symp. Diabet. Foot
75.
Zurück zum Zitat Knighton DR, Ciresi K, Fiegel VD et al (1990) Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 170:56–60PubMed Knighton DR, Ciresi K, Fiegel VD et al (1990) Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 170:56–60PubMed
76.
Zurück zum Zitat Krupski WC, Reilly LM, Perez S et al (1991) A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. J Vasc Surg Off Publ Soc Vasc Surg [and] Int Soc Cardiovasc Surgery, North Am Chapter 14:526–532 Krupski WC, Reilly LM, Perez S et al (1991) A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: a preliminary report. J Vasc Surg Off Publ Soc Vasc Surg [and] Int Soc Cardiovasc Surgery, North Am Chapter 14:526–532
77.
Zurück zum Zitat Saldalamacchia G, Lapice E, Cuomo V et al (2004) A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers. Nutr Metab Cardiovasc Dis 14:395–396CrossRefPubMed Saldalamacchia G, Lapice E, Cuomo V et al (2004) A controlled study of the use of autologous platelet gel for the treatment of diabetic foot ulcers. Nutr Metab Cardiovasc Dis 14:395–396CrossRefPubMed
78.
Zurück zum Zitat Senet P, Bon FX, Benbunan M et al (2003) Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J Vasc Surg 38:1342–1348CrossRefPubMed Senet P, Bon FX, Benbunan M et al (2003) Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J Vasc Surg 38:1342–1348CrossRefPubMed
79.
Zurück zum Zitat Stacey MC, Mata SD, Trengove NJ, Mather CA (2000) Randomised double-blind placebo controlled trial of topical autologous platelet lysate in venous ulcer healing. Eur J Vasc Endovasc Surg 20:296–301CrossRefPubMed Stacey MC, Mata SD, Trengove NJ, Mather CA (2000) Randomised double-blind placebo controlled trial of topical autologous platelet lysate in venous ulcer healing. Eur J Vasc Endovasc Surg 20:296–301CrossRefPubMed
80.
Zurück zum Zitat Weed B, Davis MDP, Felty CL et al (2004) Autologous platelet lysate product versus placebo in patients with chronic leg ulcerations: a pilot study using a randomized, double-blind, placebo-controlled trial. Wounds 16:273–282 Weed B, Davis MDP, Felty CL et al (2004) Autologous platelet lysate product versus placebo in patients with chronic leg ulcerations: a pilot study using a randomized, double-blind, placebo-controlled trial. Wounds 16:273–282
81.
Zurück zum Zitat Margolis DJ, Kantor J, Santanna J et al (2001) Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 24:483–488CrossRefPubMed Margolis DJ, Kantor J, Santanna J et al (2001) Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care 24:483–488CrossRefPubMed
82.
Zurück zum Zitat Taylor DW, Petrera M, Hendry M, Theodoropoulos JS (2011) A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med 21:344–352CrossRefPubMed Taylor DW, Petrera M, Hendry M, Theodoropoulos JS (2011) A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med 21:344–352CrossRefPubMed
83.
Zurück zum Zitat Sanchez M, Anitua E, Andia I (2010) Poor standardization in platelet-rich therapies hampers advancement. Arthroscopy 26:725–726CrossRefPubMed Sanchez M, Anitua E, Andia I (2010) Poor standardization in platelet-rich therapies hampers advancement. Arthroscopy 26:725–726CrossRefPubMed
Metadaten
Titel
Platelet biology and the rationale of PRP therapy in chronic wounds
verfasst von
Domantas Rainys
Gediminas Samulėnas
Mantas Kievišas
Eglė Samulėnienė
Loreta Pilipaitytė
Rytis Rimdeika
Publikationsdatum
18.02.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Plastic Surgery / Ausgabe 2/2017
Print ISSN: 0930-343X
Elektronische ISSN: 1435-0130
DOI
https://doi.org/10.1007/s00238-017-1279-x

Weitere Artikel der Ausgabe 2/2017

European Journal of Plastic Surgery 2/2017 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.